Sero-Prevalence of Antenatal Rubella in UITH

• Published in: The open public health journal 2011, Vol.5 (1), p.10-11
• Main Author: Agbede, O.O.
• Format: Article
• Language: English
• Subjects: Rubella virus
• ISSN: 1874-9445; 1874-9445
• DOI: 10.2174/1874944501004010010

Rubella virus is a teratogen that may induce foetal death or Congenital Rubella Syndrome in the newborn. Studies carried out in Nigeria, have recorded 68.5% prevalence in pregnant women in the south-west and 54.1% in the North-west. There has been a dearth of information in the North central. Sentinel studies have placed the incidence of rubella on a seasonal distribution, with an average of 5-9-year variable epidemic pattern. A descriptive study was carried out on pregnant women between July and September 2009, to establish baseline data on the sero-prevalence of antenatal rubella in pregnant women in Ilorin. A total of 92 pregnant women in the first and second trimesters of pregnancy were recruited from the antenatal clinics of the University of Ilorin Teaching Hospital. A 3ml blood sample was collected from each consenting subject and serum assayed for Rubella IgG/ IgM antibodies by indirect ELISA test. Anti-rubella virus antibodies were reported in the sera of 14 pregnant women that participated in the study. A prevalence of 16.3% was recorded. The primigravidae had a higher prevalence (27.0%) than the multigravidae (12.0%). There was a gradual rise in seroprevalence from first trimester pregnancies (13.0%) to second trimester pregnancies (19.1%). High seroprevalence of rubella infections during organogenesis poses high risk to foetus. Since 85% of the subjects were susceptible to rubella virus infection, it is advisable for health planners to prevent further occurrence of antenatal rubella that may result to congenital rubella anomalies by the immunisation of women of child bearing age.